Obermatt

Medios

GER:ILM1 · DE000A1MMCC8
Health Care Providers & ServicesMedium

360

98
EV / EBIT87
Price / Owner Earnings60
Owner Earnings Yield94
Dividend Yield1
Price/Sales100
EV / Gross Profit85
Price/Book95
Return on Capital50
Cash Return on Capital64
Return on Equity38
EBIT Margin27
Gross Profitability47
Cash Conversion84
Accruals59
Owner Earnings Margin42
Sales growth22
Profit Growth29
Long-Term EPS Growth91
Owner Earnings Growth43
Reinvestment98
Price momentum67
Debt load69
Refinancing92
Debt Payback55
Liquidity32
Analyst ratings100
Opinion Changes50
Price Target Upside95
Market mood15
Value Creation10/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Medios clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountryGermany
IndustryHealth Care Providers & Services
SizeMedium
TypePublic Company
ExchangeXTRA
Employees107
ISINDE000A1MMCC8
Last UpdateApr 2, 2026
Themes
OphthalmologyImmunologyHematologyOncologyNeurologyHepatologyManufacturingMedicalPharmaceuticalTherapeutics

Description

Medios AG is committed to creating a global platform to provide innovative pharmacotherapies wherever required. This dedication underpins the company's core mission to facilitate the availability of cutting-edge, tailored medical solutions to individ…

Analysis

Bargain bin

Medios AG falls in the bargain bin: the price is low relative to peers, but the business metrics give reason to pause.

The price is attractive. You pay 7.5× its owner earnings: the cash an owner could take out each year, which is in the historically attractive zone. At today's price, the market is assuming roughly -7% yearly growth; analysts expect 39%. The price, in other words, assumes less than the experts do.

The trajectory is moderate and the balance sheet is sturdy. The company scores 10/20 on our value-creation score: creating some value. Analysts lean positive.

Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
88
2023202420252026

All-time high

100

Dec 2025

All-time low

47

Jun 2023

Average rank

91

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
100
93
89
85
Price/Earnings
74
85
72
50
Price/Book
95
95
90
72
Dividend Yield
1
1
1
1
Value (overall)
81
72
65
62

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Medios with its peers
Spire
LSE:SPI
38
CountryUK
IndustryHealth Care Providers & Services
SizeLarge
Full Stock Analysis →
Uniphar
ISE:UPR
59
CountryIreland
IndustryHealth Care Providers & Services
SizeMedium
Full Stock Analysis →
InMode
NSQ:INMD
86
CountryIsrael
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Alcon
VTX:ALC
51
CountrySwitzerland
IndustryHealth Care Equipment & Supplies
SizeX-Large
Full Stock Analysis →
Carl Zeiss Meditec
GER:AFX
50
CountryGermany
IndustryHealth Care Equipment & Supplies
SizeLarge
Full Stock Analysis →
Siemens Healthineers
GER:SHL
17
CountryGermany
IndustryHealth Care Equipment & Supplies
SizeX-Large
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →